Biolife Solutions Inc
Research Biolife Solutions Inc (BLFS) on Bullrun: market cap USD 1.38B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBLFS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 1.38B
- Financial periodFY2025
- RevenueUSD 96.21M
- Revenue growth28.9%
- Net income-USD 4.60M
- Free cash flowUSD 10.64M
- Gross margin64.6%
Valuation Snapshot
latest market cap is USD 1.38B.
About Biolife Solutions Inc
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.
Frequently asked questions
What is Biolife Solutions Inc's market cap?
Biolife Solutions Inc's market capitalization is USD 1.38B.
What does Biolife Solutions Inc do?
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.